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Journal of Hepatology 48 (2008) S1ForewordThe Journal of Hepatology supplement has become a
fortunate tradition providing a high quality updated
overview on liver diseases, therapy and management.
This last edition represents a major eﬀort of the Milan
Editorial Oﬃce in an attempt to provide high quality,
evidence-based updated information on what we think
are the most challenging topics of modern hepatology.
Our team of Associate Editors, as leading specialists in
their own ﬁelds, gives us an excellent overview on the
most important advances in hot areas of liver pathology
worldwide. It is particularly rewarding that signiﬁcant
progress has been made in many ﬁelds and that basic re-
search has largely become translational in nature, inas-
much as new concepts in liver disease management are
now based on newly discovered basic pathogenetic
mechanisms. The supplement focuses mostly on classical
topics including cirrhosis and its complications, novel
approaches to management of hepatocellular carci-
noma, future treatment options of chronic hepatitis B,
as well as fashionable topics of growing interest such
as non-alcoholic fatty liver disease and classical ones
such as iron, cholestasis and gallstones. The list has been
deliberately limited to accommodate areas of major0168-8278/$34.00  2008 European Association for the Study of the Liver.
doi:10.1016/j.jhep.2008.02.003clinical relevance or those that needed appropriate
updating.
Over the past year, we have seen a signiﬁcant rise of
the Journal of Hepatology impact factor and we feel that
this is the result of a joint eﬀort between the old and the
new Editorial Oﬃces in the quest for scientiﬁc quality.
The review articles of the supplement contain invaluable
information which provide an excellent reference point
for the widest readership. The Journal has now become
an excellent means of conveying experimental data
useful in clinical practice and it is precisely with this
aim that the editors decided to produce a distillate of
these in ‘‘Management of Liver Diseases 2008”. We
hope you like it.
Last but not least, we wish to acknowledge the ﬁnan-
cial support of EASL without which this supplement
could never have been published.
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